Nova One Advisor

The global primary cell culture market was valued at USD 5.65 billion in 2025 and is projected to reach USD 16.78 billion by 2035, expanding at a CAGR of 11.5%. Growth is being fueled by rising demand for cell & gene therapy development, personalized medicine, vaccine production, and advanced disease modeling.

Key Market Highlights

• North America led the market with 45% share in 2025, supported by strong biotech infrastructure and research funding. • Reagents & supplements held a major market share due to increasing demand for optimized culture environments. • Enzymatic degradation remained the preferred separation method for isolating viable cells from complex tissues. • Animal cells dominated by cell type in 2025, while cell & gene therapy development emerged as the leading application segment.

Top Trends Driving the Market

• Increased use of human-derived primary cells for better translational outcomes • Growing adoption of serum-free, xeno-free, and chemically defined media • Rising focus on 3D culture systems and co-culture models • Integration of AI and machine learning to optimize cell culture workflows • Expanding role of primary cells in vaccine and viral vector research

Regional Outlook

While North America continues to dominate, Asia-Pacific is expected to witness the fastest growth due to increasing investments in biotech, regenerative medicine, CROs, and healthcare innovation across China, India, Japan, and South Korea.

Leading Companies

The global Lyophilization Equipment and Services Market was valued at USD 5.55 billion in 2025 and is projected to reach USD 13.09 billion by 2035, growing at a CAGR of 8.96%.

Freeze-drying technology is becoming increasingly important across the healthcare industry, especially for preserving biologics, vaccines, injectable drugs, and advanced therapies. As pharmaceutical companies focus more on temperature-sensitive treatments, demand for advanced lyophilization systems continues to grow.

What’s driving market growth?

• Rising demand for biologics and vaccines • Expansion of pharmaceutical CDMO outsourcing • Technological innovations in automated and energy-efficient freeze-drying systems • Growing use of AI and IoT for process optimization and predictive maintenance

Key Highlights

• North America led the market in 2025 • Asia Pacific is expected to witness the fastest growth through 2035 • Consumables & accessories dominated by modality • Services segment is projected to grow the fastest • Pharmaceutical & biotechnology companies remain the largest application area

AI is also emerging as a major growth catalyst, helping manufacturers improve product consistency, reduce cycle variability, and enhance equipment efficiency.

The global Stationary Energy Storage Market is entering a high-growth phase as countries, utilities, and industries race to build more resilient and renewable-powered energy systems. Valued at USD 50.84 billion in 2025, the market is projected to reach USD 440.48 billion by 2035, expanding at a remarkable CAGR of 24.1%.

Why the Market is Growing

As renewable energy sources like solar and wind become more common, the need for reliable storage solutions is becoming critical. Since renewable energy generation often doesn’t align perfectly with electricity demand, stationary energy storage systems help by storing excess power and releasing it when needed.

These systems are now playing a major role in:

Grid stabilization

Backup power during outages

Renewable energy integration

Peak load management

Energy cost optimization

Major Companies in the Market

Some of the leading players shaping the stationary energy storage landscape include:

Tesla

Panasonic Corporation

Samsung SDI

Toshiba Corporation

Exide Technologies

Durapower

Duracell

Johnson Controls

Philips

The global lyophilization equipment and services market is gaining strong momentum as pharmaceutical and biotech companies increasingly rely on freeze-drying technology to preserve the stability of biologics, vaccines, and injectable drugs. The market was valued at USD 5.55 billion in 2025 and is projected to reach USD 13.09 billion by 2035, growing at a CAGR of 8.96%.

What is Driving Market Growth?

Rising demand for temperature-sensitive therapies is fueling market expansion.

Increased use of biologics, vaccines, injectable drugs, cell therapies, and gene therapies is creating strong demand for freeze-drying solutions.

Lyophilization helps:

Extend product shelf life

Maintain drug potency

Improve storage stability

Reduce cold-chain dependency

Technology Trends Shaping the Market

Modern lyophilization systems are becoming more advanced with:

Artificial Intelligence (AI)

IoT-based monitoring

Predictive maintenance

Energy-efficient equipment designs

These innovations help improve:

Operational efficiency

Production reliability

The global High-performance Liquid Chromatography (HPLC) market was valued at USD 5.44 billion in 2025 and is projected to reach USD 8.44 billion by 2035, growing at a CAGR of 4.49% from 2026 to 2035.

What’s Driving Market Growth?

The market is gaining momentum due to:

Rising demand from pharmaceutical and biotech industries

Increasing use of HPLC in drug discovery and quality control

Growing investment in life sciences and academic research

Strict FDA and EMA regulatory compliance requirements

Expanding applications in clinical research and diagnostics

Regional Outlook

The HPLC market spans major regions including:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Among these, Asia Pacific is expected to witness notable growth due to expanding pharmaceutical manufacturing and research infrastructure in countries like China, India, and Japan.

Leading Companies in the HPLC Market

Key players shaping the competitive landscape include:

Waters Corporation

Agilent Technologies

Shimadzu Corporation

Thermo Fisher Scientific

As air pollution continues to impact public health, urban development, and industrial operations worldwide, the Air Quality Monitoring System Market is witnessing strong momentum. According to recent market insights, the global market was valued at USD 6.19 billion in 2025 and is projected to grow to USD 12.52 billion by 2035, expanding at a CAGR of 7.3% during the forecast period.

Why the Market is Growing

Air quality monitoring systems have become increasingly important due to the growing burden of respiratory illnesses, industrial emissions, and urban pollution. Governments, industries, and consumers are actively investing in advanced monitoring technologies to ensure safer environments and regulatory compliance.

Key Industry Players

Some of the major companies shaping the competitive landscape include:

Thermo Fisher Scientific

Emerson Electric

General Electric

Siemens AG

Teledyne Technologies

These companies are focusing on innovation in sensor technology, portable devices, AI integration, and industrial compliance solutions to strengthen their market position.

Regional Outlook

The market shows strong opportunities across:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Final Thoughts

The global transcatheter embolization and occlusion devices market was valued at USD 6.33 billion in 2025 and is projected to reach USD 12.14 billion by 2035, expanding at a CAGR of 7.5% during the forecast period.

Growth in this market is being fueled by the increasing demand for minimally invasive procedures, the rising burden of cancer and vascular diseases, and the growing use of embolization technologies in emergency and chronic care settings.

Why the Market is Expanding

Rising use of interventional radiology in oncology and vascular care

Increasing preference for safer, less invasive treatment options

Growing adoption of liquid embolic agents, vascular plugs, and drug-eluting beads

Expansion of advanced treatment capabilities in hospitals and ambulatory surgical centers

Key Market Highlights

Non-coil devices are seeing strong traction due to innovation and broader use in complex procedures

Liquid embolic agents are emerging as one of the fastest-growing segments, especially in neurovascular and tumor-related applications

Oncology continues to dominate application demand, supported by the increasing use of TACE and tumor embolization

Hospitals remain the leading end-users, while ambulatory surgical centers are gaining momentum due to cost-effective outpatient care

Leading Companies

Major players shaping the market include:

BTG plc

Boston Scientific Corporation

Medtronic plc

Penumbra, Inc.

The global Platelet Rich Plasma (PRP) market is gaining strong momentum as demand rises for non-surgical regenerative therapies across orthopedics, sports medicine, dermatology, and aesthetics. According to industry analysis, the market was valued at USD 650.13 million in 2025 and is projected to reach USD 2,246.28 million by 2035, expanding at a CAGR of 13.2% during the forecast period.

Key Market Highlights

North America dominated the PRP market in 2025 due to strong healthcare infrastructure and high adoption of regenerative therapies.

Asia Pacific is expected to witness the fastest growth through 2035, driven by expanding healthcare access, rising aesthetic awareness, and medical tourism.

Pure PRP held the largest market share in 2025 because of its safety profile and broad use across multiple applications.

Leukocyte Rich PRP is expected to grow at the fastest pace due to its use in treating more complex orthopedic and sports injuries.

Orthopedics remained the leading application segment, while dermatology is projected to be the fastest-growing area.

Hospitals led the market by end use, though clinics are expected to grow rapidly due to convenience and outpatient demand.

Challenges to Watch

Despite strong growth, the market still faces limitations such as high treatment costs and limited reimbursement coverage. Since many PRP procedures are considered elective or off-label, patients often have to pay out of pocket, which can restrict broader adoption.

Competitive Landscape

Leading players operating in the market include:

Johnson & Johnson Services, Inc.

Arthrex, Inc.

EmCyte Corporation

Dr. PRP USA LLC

The global cell therapy human raw materials market is on a rapid growth trajectory, projected to surge from USD 4.75 billion in 2025 to USD 25.76 billion by 2035, expanding at an impressive CAGR of 18.42%. This growth reflects the rising demand for cutting-edge treatments like CAR-T, stem cell, and regenerative therapies.

💡 What’s Driving the Market? The increasing prevalence of chronic diseases, growing clinical trials, and the shift toward allogeneic (off-the-shelf) therapies are fueling demand for high-quality raw materials such as cell culture media, growth factors, and human serum.

AI is Changing the Game Artificial intelligence and machine learning are revolutionizing the industry by improving donor selection, optimizing raw material sourcing, and enhancing production quality through real-time monitoring and predictive analytics.

Regional Insights

North America leads the market with strong R&D and infrastructure

Asia Pacific is the fastest-growing region due to cost efficiency and government support

Key Trends to Watch

Shift toward xeno-free and chemically defined media

Rising role of CDMOs and CROs in large-scale production

Automotive Emission Testing Market Snapshot The market was valued at USD 799.37 billion in 2025 and is projected to reach USD 1,314.27 billion by 2035, growing at a CAGR of 5.1% (2026–2035).

🔍 Key Takeaways

🇪🇺 Europe dominated the market with a 36% revenue share in 2025, driven by strict emission norms (Euro standards).

Emission test equipment led the solution segment with 47.1% share.

Other emission testing components accounted for a massive 87% share globally.

📈 Growth Drivers

Stringent global emission regulations

Rising vehicle production in emerging economies

Technological advancements like PEMS & real-time monitoring systems

Expansion of periodic inspection & automotive aftermarket services

Electric Vehicle Transmission Market Snapshot

The global EV transmission market size was valued at USD 8.04 billion in 2025 and is expected to reach USD 32.39 billion by 2035, expanding at an impressive CAGR of 14.95% (2026–2035).

What’s Driving Growth?

As electric vehicles continue to gain traction worldwide, the demand for advanced transmission systems is rising rapidly. Unlike traditional vehicles, EVs require highly efficient, lightweight, and compact transmission solutions to maximize performance and battery efficiency.

Key Trends to Watch:

Growing adoption of single-speed and multi-speed transmissions

Continuous innovation in lightweight and energy-efficient components

Rising demand for high-performance EVs

Increasing investments from leading automotive and tech players

Market Momentum: Government incentives, stricter emission regulations, and rapid EV adoption across regions like North America, Europe, and Asia-Pacific are fueling market expansion.

The automotive air filters market was valued at USD 4.94 billion in 2025 and is projected to reach approximately USD 8.49 billion by 2035, expanding at a CAGR of 5.56% from 2026 to 2035.

What’s Driving the Market?

Rising vehicle production and ownership worldwide

Increasing awareness about engine performance and fuel efficiency

Stringent emission regulations pushing demand for high-quality filters

Growth in aftermarket sales and regular maintenance cycles

Key Trends to Watch:

Shift toward advanced filtration technologies

Growing adoption of eco-friendly and reusable filters

Expansion of electric and hybrid vehicles influencing filter design innovations

The global particle counter market is on a strong upward trajectory. Valued at USD 684.70 million in 2025, it is projected to reach USD 1,696.85 million by 2035, growing at a CAGR of 9.5% during the forecast period.

Market Segmentation

By Type:

Handheld Particle Counters: Portable and ideal for on-site monitoring.

Portable Particle Counters: Compact and widely used for quick environmental assessments.

Continuous Particle Counters: Provide real-time monitoring in controlled environments.

By End User:

Pharmaceutical & Biotech Companies: Ensuring compliance with cleanroom standards.

Electronics & Semiconductor Industry: Monitoring contamination in highly sensitive manufacturing processes.

Environmental & Research Labs: Tracking air quality and particle contamination in labs and research facilities.

By Application:

Cleanroom Monitoring: Critical for controlled environments in pharmaceuticals and semiconductors.

Air Quality Monitoring: Used in environmental studies, industrial safety, and pollution control.

Liquid Contamination Testing: Important for industrial liquids, water treatment, and chemical processes.

Regional Outlook

North America and Europe dominate the particle counter market due to advanced healthcare infrastructure, strict regulatory compliance, and high adoption of cleanroom technologies. However, Asia-Pacific is emerging as a high-growth region, driven by the booming pharmaceutical sector, rising electronics manufacturing, and increased environmental monitoring initiatives.

Why the Market is Growing

Stringent Regulatory Standards: Agencies like the FDA and ISO enforce strict particle monitoring guidelines.

Technological Advancements: Modern particle counters are more accurate, portable, and integrated with IoT for real-time data.

The global Effective Microorganisms (EM) market is on a promising growth trajectory. Valued at USD 383.55 million in 2025, the market is expected to reach USD 904.68 million by 2035, expanding at a CAGR of 8.96% during the forecast period from 2026 to 2035.

Key Drivers of Market Growth:

Rising demand for sustainable farming: As farmers seek eco-friendly alternatives to chemical fertilizers, EM products offer an effective solution for soil enrichment and increased yield.

Environmental awareness: Growing concerns over soil degradation, water pollution, and waste management are driving the adoption of EM-based solutions.

Expansion into diverse applications: From agriculture and aquaculture to composting and wastewater treatment, the versatility of EM is widening its market reach.

Regional Insights: North America and Europe are witnessing steady growth due to increasing awareness of sustainable agriculture and government initiatives supporting eco-friendly farming practices. Meanwhile, Asia-Pacific is expected to emerge as a major growth hub, driven by intensive agriculture, rising population, and a strong focus on organic farming.

Market Trends to Watch:

Integration of EM with biofertilizers and biopesticides to enhance soil productivity.

Adoption in urban farming and vertical farming solutions to improve yield and maintain soil health.

The global mHealth solutions market is on a rapid growth trajectory, reflecting the increasing adoption of mobile technologies in healthcare. Valued at USD 192.68 billion in 2025, the market is projected to skyrocket to USD 2,099.87 billion by 2035, expanding at an impressive CAGR of 26.98% over the forecast period.

Key Drivers of Growth:

Digital Health Adoption: Patients and healthcare providers are increasingly relying on mobile apps and wearable devices for real-time health monitoring.

Remote Patient Monitoring: The COVID-19 pandemic accelerated the adoption of virtual healthcare, creating long-term demand for mobile solutions.

Healthcare Cost Optimization: mHealth reduces hospital visits and enables early intervention, leading to more affordable healthcare.

Technological Advancements: Integration of AI, IoT, and cloud-based solutions is enhancing the functionality of mHealth platforms.

The global Particle Size Analysis (PSA) market is steadily gaining momentum, and for good reason. Valued at USD 501.13 million in 2026, it’s projected to soar to around USD 897.44 million by 2035, growing at a healthy CAGR of 6% over the forecast period.

Why the Growth Surge? The market’s expansion is being driven by:

Nanotechnology research pushing the need for precise particle measurement

Pharmaceutical and biotech innovation, where particle size impacts drug delivery and stability

Stringent regulatory standards demanding consistent quality and precision

Global Reach 🌍 The PSA market spans:

North America (U.S., Canada)

Europe (Germany, France, UK, Rest of Europe)

Asia-Pacific (China, Japan, India, Southeast Asia)

Latin America (Brazil, Rest of LATAM)

The healthcare landscape is undergoing a major transformation, and Digital Therapeutics (DTx) is at the forefront of this evolution. By combining technology with evidence-based medical interventions, DTx solutions are redefining how chronic diseases and mental health conditions are managed.

💡 Market Snapshot The global Digital Therapeutic (DTx) market was valued at USD 6.35 billion in 2025 and is projected to skyrocket to USD 67.69 billion by 2035, expanding at a remarkable CAGR of 26.7% over the forecast period.

What’s Driving This Growth?

Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions

Increasing adoption of smartphones and connected healthcare devices

Growing demand for personalized and remote patient care solutions

Strong regulatory support and increasing approvals for digital therapeutics

Why DTx Matters Digital therapeutics go beyond wellness apps—they deliver clinically validated treatments, often prescribed by healthcare providers, helping patients manage conditions through behavioral interventions, real-time monitoring, and data-driven insights.